The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone

被引：0

作者：

Constance Delaby

Teresa Estellés

Nuole Zhu

Javier Arranz

Isabel Barroeta

María Carmona-Iragui

Ignacio Illán-Gala

Miguel Ángel Santos-Santos

Miren Altuna

Isabel Sala

M. Belén Sánchez-Saudinós

Laura Videla

Sílvia Valldeneu

Andrea Subirana

Mireia Tondo

Francisco Blanco-Vaca

Sylvain Lehmann

Olivia Belbin

Rafael Blesa

Juan Fortea

Alberto Lleó

Daniel Alcolea

机构：

[1] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,Sant Pau Memory Unit, Department of Neurology

[2] Universitat Autònoma de Barcelona,Servei de Bioquímica i Biologia Molecular

[3] IRMB,undefined

[4] INM,undefined

[5] Université de Montpellier,undefined

[6] INSERM,undefined

[7] CHU de Montpellier,undefined

[8] Laboratoire de Biochimie-Protéomique clinique,undefined

[9] Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas,undefined

[10] CIBERNED,undefined

[11] Fundació Catalana Síndrome de Down,undefined

[12] Centre Mèdic Down,undefined

[13] Servei de Bioquímica,undefined

[14] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,undefined

[15] Universitat Autònoma de Barcelona,undefined

[16] Unversitat Autònoma de Barcelona,undefined

[17] Centro de Investigación Biomédica en Red en Diabetes y Enfermedades Metabólicas (CIBERDEM),undefined

来源：

Alzheimer's Research & Therapy | / 14卷

关键词：

Amyloid; Aβ1–40; Aβ1–42; Cerebrospinal fluid; Tau; Biomarkers;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Plasma p-tau181/A beta(1-42) ratio predicts A beta-PET status and correlates with CSF-p-tau181/A beta(1-42) and future cognitive decline
Fowler, Christopher J.
Stoops, Erik
Rainey-Smith, Stephanie R.
Vanmechelen, Eugeen
Vanbrabant, Jeroen
Dewit, Nele
Mauroo, Kimberley
Maruff, Paul
Rowe, Christopher C.
Fripp, Jurgen
Li, Qiao-Xin
Bourgeat, Pierrick
Collins, Steven J.
Martins, Ralph N.
Masters, Colin L.
Doecke, James D.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2022, 14 (01)
[22] Ventricular volume in relation to lumbar CSF levels of amyloid-β 1–42, tau and phosphorylated tau in iNPH, is there a dilution effect?
Simon Lidén
Dan Farahmand
Katarina Laurell
Fluids and Barriers of the CNS, 19
[23] Ratio of Aβ42/P-tau181p in CSF is associated with aberrant default mode network in AD
Li, Xiaozhen
Li, Tie-Qiang
Andreasen, Niels
Wiberg, Maria Kristoffersen
Westman, Eric
Wahlund, Lars-Olof
SCIENTIFIC REPORTS, 2013, 3
[24] CSF Aβ1–42, but not p-Tau181, Predicted Progression from Amnestic MCI to Alzheimer’s Disease Dementia
Liara Rizzi
Luciane Missiaggia
Matheus Roriz-Cruz
NeuroMolecular Medicine, 2018, 20 : 491 - 497
[25] Aβ1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: Indication of reversible Aβ1-42 aggregation?
Sancesario, Giulia M.
Esposito, Zaira
Nuccetelli, Marzia
Bernardini, Sergio
Sorge, Roberto
Martorana, Alessandro
Federici, Giorgio
Bernardi, Giorgio
Sancesario, Giuseppe
EXPERIMENTAL NEUROLOGY, 2010, 223 (02) : 371 - 376
[26] CSF Aβ1-42 Levels and Glucose Metabolism in Alzheimer's Disease
Dumurgier, Julien
Paquet, Claire
Peoc'h, Katell
Lapalus, Pauline
Mouton-Liger, Francois
Benisty, Sarah
Chasseigneaux, Stephanie
Chabriat, Hughes
Hugon, Jacques
JOURNAL OF ALZHEIMERS DISEASE, 2011, 27 (04) : 845 - 851
[27] Stability of CSF β-amyloid1-42 and tau levels by APOE genotype in Alzheimer patients
Huey, Edward D.
Mirza, Nadeem
Putnam, Karen T.
Soares, Holly
Csako, Gyorgy
Levy, James A.
Copenhaver, Brittany
Cohen, Robert M.
Sunderland, Trey
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2006, 22 (01) : 48 - 53
[28] Ventricular volume in relation to lumbar CSF levels of amyloid-β 1-42, tau and phosphorylated tau in iNPH, is there a dilution effect?
Liden, Simon
Farahmand, Dan
Laurell, Katarina
FLUIDS AND BARRIERS OF THE CNS, 2022, 19 (01)
[29] How to handle adsorption of cerebrospinal fluid amyloid β (1-42) in laboratory practice? Identifying problematic handlings and resolving the issue by use of the Aβ42/Aβ40 ratio
Willemse, Eline
van Uffelen, Kees
Brix, Britta
Engelborghs, Sebastiaan
Vanderstichele, Hugo
Teunissen, Charlotte
ALZHEIMERS & DEMENTIA, 2017, 13 (08) : 885 - 892
[30] Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer's disease with PS1 mutations
Ikeda, Masaki
Yonemura, Kimie
Kakuda, Satoko
Tashiro, Yuichi
Fujita, Yukio
Takai, Eriko
Hashimoto, Yukiko
Makioka, Kouki
Furuta, Natsumi
Ishiguro, Koichi
Maruki, Risa
Yoshida, Jun'ichi
Miyaguchi, Osamu
Tsukie, Tamao
Kuwano, Ryouzou
Yamazaki, Tsuneo
Yamaguchi, Haruyasu
Amari, Masakuni
Takatama, Masamitsu
Harigaya, Yasuo
Okamoto, Koichi
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2013, 20 (02): : 107 - 112

← 1 2 3 4 5 →